To minimize differences in apolipoprotein measurements among laboratories and methods, a standardization program involving common suitable reference material is needed. The Committee on Apolipoproteins of the International Federation of Clinical Chemistry initiated a collaborativestudy for the standardization of test systems for measuring apolipoproteins (apo) A-I and B, with 25 company laboratories and three research laboratories involved in apolipoprotein analysis to: (a) evaluate calibration differences among the test systems; (b) evaluate whether comparability of the data can be achievedwith the use of frozen serum pools to recalibrate the different systems; and (c) evaluate and select suitable candidate referencematerial.We used 26 test systems for apo A-I and 28 for apo B. Relatively modest differences were found in calibration for apo A-I, but very wide differences were observed for apo B methods. After uniform calibration, the overall among-laboratory CV for apo B decreased from 19% to 6%. Three lyophilized serum preparations for apo A-I and three liquid-stabilized serum preparations for apo B were selected for further evaluation as candidate international reference materials.
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Recent years have seen an increase in the clinical and epidemiological studies that include determination of apolipoproteins (apo) A-I and B with the other indices of risk of coronary artery disease.4 Even though the large amounts of data generated by these studies have not always been in agreement, overall the conclusions support the clinical usefulness of apo A-I and B measurements. As a result, commercially available methods for measuring these proteins in human serum have prolif. erated.
Despite the effort of the Lipid Apoprotein Subcommittee of the International Union of Immunological Societies and the Centers for Disease Control (CDC) to standardize apo A-I and B measurements by providing a lyophilized serum pool with assigned consensus values for apo A-I and B, the among-laboratory coefficient of variation (CV) determined in different surveys decreased only from 19% to 14% for apoA-Iandfrom3O%to23%forapoB(1). 
Materials and Methods

Participants inthe Standardization Program
Twenty-eight laboratories from nine countries participated in the standardization study, performing the analyses or providing candidate secondary serum reference materials (SSRMs) ( Table 1 and 2). For ape A-I, 15 SSRMs were proposed (A1-A15). Nine of these were lyophilized preparations (A4-A8, A1O-A13); the remaining six were liquid (A1-A3, A9, A14, A15). Eleven SSRMs for ape B from seven participants were proposed: nine were in liquid stabilized form (B1-B4, B7-B11) and two were lyophilized (B5, B6). Partici- 
Sera from individualSubjects
Interim serum reference materials (ISRM) for ape A-I and B were prepared by the coordinating laboratory (NWLRL); they served as a point of reference for the intermethod comparison of values. Donors for the respective serum pools were selected on the basis of concentrations of ape A-I and B (low, normal, and high), and triglyceride concentrations <1.6 g/L. Blood was collected with a butterfly needle and 50-mL syringes from reclining subjects who had fasted 12-14 h. After coagulation, the blood was centrifuged at 4#{176}C and the serum transferred to 50-mL centrifuge tubes for recentrifugation to remove remaining cells and fibrin. Aliquota from each donor had been previously analyzed and found negative for antibodies against human immunedeficiency virus-i or hepatitis B surface antigen. Fresh sera were pooled and filtered through a 0.22-inn poresize filter (Costar, Cambridge, MA). Under constant stirring in an ice bath, each pool was transferred in 1-mL aliquots into labeled cryogenic plastic vials (Nunc, Inc., Naperville, IL) by an automated dispenser (Digiflex; ICN Biomedicals, Irvine, CA). The vials were capped with color-coded tops, placed in boxes, and frozen at -70 #{176}C immediately.
Additional aliquots of serum from 10 subjects were also transferred into cryogenic plastic vials and frozen immediately at -70 #{176}C. These sera represented the normotriglyceridemic samples from individual subjects.
Preparation of Primary ReferenceMaterial
For ape B, low-density lipoprotein (LDL; density 1.030-1.050 kg/L) was isolated from a freshly prepared pool of plasma from six normolipidemic subjects (triglyc-eride <1.4 g/L, cholesterol <2.4 g/L) by sequential ultracentrifugation as described (5). Total protein mass was assigned by a standardized sodium dodecyl sulfateLowry procedure (5). For ape A-I, Reference Material no. 393 (Community Bureau of Standards of the European Communities) was used as primary reference material; its protein concentration was 1.07 g/L, determined by amino acid analysis.
Assignment of Target Values
The target values of the frozen serum pools used as interim reference materials in this study were assigned by the NWLRL by use of a nephelometric assay in which the analytical conditions (e.g., choice of buffer, detergent, incubation time, concentration range) were optimized to achieve a superimposable immunochemical behavior between the primary reference materials and fresh-frozen serum pools (6) . Using purified ape A-I and LDL of 1.030-1.050 kg/L as primary reference material, we analyzed each serum pool 15 times a day on three separate days. The same ape B mean values were obtained by an RIA, performed as previously described (7), but higher standard deviations were observed.
Study Protocol
The participants were requested to calibrate their methods daily by using their inhouse calibrator, and to follow a common detailed protocol on how to thaw and equilibrate the frozen serum pools and how to reconstitute and equilibrate the lyophilized preparations.
The ISRMa provided had either low, normal, or high concentrations of ape A-I or B, and the participants were requested to form pools with intermediate concentrations of ape A-I and B by combining an equal volume of the low pool (1.09 g/L for ape A-I and 0.66 g/L for ape B) with the normal pool (1.28 or 1.11 g/L, respectively) and of the normal pool with the high pool (1.64 or 1.65 g/L, respectively) just before the analyses, to create a fivepoint curve. Each concentration of the ISRM and the proposed SSRMs was analyzed in duplicate on five different days by each method. The ISRMs were analyzed in a palindrome sequence, from the lowest to the highest concentration of analyte and then from the highest to the lowest concentration.
All the data were recorded on report forms provided.
At the completion of this study, the participants were requested to analyze in duplicate on two different days the 10 fresh-frozen serum samples provided to verify accurate system calibration. Some participants also conducted dilution studies with the proposed SSRMs.
In addition to the quantitative analyses performed by all laboratories involved in the study, one laboratory (Foundation for Blood Research) also analyzed the physicochemical characteristics of the SSRMs by agarose gel electrophoresis (Titan Gel Multi-Slot Lipo-17; Helena Labs., Beaumont, TX). Each candidate SSRM, along with a fresh normal serum pool for comparative purposes, was electrophoresed and stained for lipid with Fat Red 7B. In a separate but related experiment, the SSRMs were thawed or reconstituted according to the protocol, and the contents of each vial were transferred to clear 10 x 50 mm stoppered tubes and refrigerated at 4#{176}C for seven days. By using narrow tubes, we could detect physical changes in the serum visually and grade each SSRM according to its physical clarity and whether or not a lipid layer or precipitate formed during storage.
We used 26 systems for ape A-I and 28 systems for ape B in this study. Among the ape A-I systems, 15 were turbidinietric assays, six were nephelometric assays, three were radial immunodiffusion assays, and two were RIAs. Among the ape B systems, 16 were turbidimetric assays, six were nephelometric assays, four were radial immunodiffusion assays, and two were RIAs.
Data Analysis
We calculated a calibration constant (K) for each method by using the ratio between the assigned and the observed values at each concentration of the ISRM. The K factor was used to evaluate the difference among the calibrations of the test systems. For each method, the ape A-I and B concentrations obtained for each candidate SSRM or subject sample were corrected by multiplying the mean of the replicates by the method-specific K factor. We computed the system mean of the corrected values for each SSRM and subject sample. Apelipoprothin values for each SSRM and subject sample were then screened for outliers. All the values that exceeded the system mean value by ±3 SD were defined as outliers and eliminated from analyses. One-way analysis of variance was used to estimate the proportion of variation attributable to among-and within-laboratory error.
Results
Analyses of the Differenceamong Calibrations
Participants were divided into two groups, based on the initial approach used by each laboratory to assign the target value to the calibrators of each system. The first group used CDC Serum Pool 1883 to transfer the ape A-I and B values to their calibrators; the second group used purified ape A-I and isolated LDL (primary reference materials) to assign the values to their calibrators. The K factor for ape A-I varied from 0.96 to 1.19 (Table 3 ) with a mean of 1.08 (SD 0.07). The mean constant obtained by the first group, 1.11 (SD 0.05), was significantly higher (P <0.05) than that obtained by the second group, 1.04 (SD 0.06). The K factor for ape B varied more than that for ape A-I, ranging from 0.97 to 1.77 with a mean of 1.35 (SD 0.26). The mean constant obtained by the first group, 1.52 (SD 0.18) was by far greater than that obtained by the second group, 1.14 (SD 0.17).
The CV of five calibration constants obtained at each concentration of the ISRM were <5% for most systems (Table 3) , with only one ape A-I system and three ape B systems having CVs >5%. Thus, for most systems, use 
Harmonization of the Data
The ape A-I concentration obtained for 10 samples from normotriglyceridemic subjects demonstrated a reasonably good agreement between the test systems. Before uniform calibration, the mean CV of the ape A-I values was 6.9% (Table 4) . After application of the K-factor correction to adjust the calibrators to the ISRM, the mean CV among the different systems for ape A-I was reduced to 5%. A wide variation in ape B values was obtained by the different systems, with a mean CV of 19.0% (Table 4) . Applying the K-factor correction improved the ape B results dramatically, with a mean CV among methods of 6.3%.
Evaluation and Selection of Candidate SSRMs
The candidate SSRMS prepared by several participants (for ape A-I, nine lyophilized and six liquid serum preparations; for ape B, nine liquid and two lyophilized serum preparations) were evaluated in the different test systems before and after the common calibration. All but three of the SSRMs for ape A-I had a mean withinassay CV <6%, whereas all of the SSRMs for ape B had a within-assay CV <6% (Table 5) . Thus, the withinassay precision of most SSRMs was satisfactory.
In contrast, the mean between-assay CV was highly variable both before and after uniform calibration (Table 5) . For ape A-I, the between-assay CV alter calibration ranged from 4.4% to 80.6%, with only five preparations (A4, A5, A8, All, A12) having a CV <7%. The between-assay CV of the SSRMs for ape B after calibration was also highly variable, ranging from 6.0% to 35.1%, with only three preparations having a CV 7% (B2, B7, B8). Thus, five preparations for ape A-I and three for ape B were initially selected as candidate SSRMs because they did not exhibit significant matrix interactions;
i.e., the results of all test systems agreed, with a CV 7%. The second criterion for acceptance of the candidate a low blank in nephelometry.
The data in Table 6 An analysis of variance was performed to determine the proportion of variation attributable to among-and withinlaboratory error for the SSRMs after application of the uniform calibration procedure Clable 7). The majority of laboratory variation was among-laboratory error, ranging from 43% to 97% of the total error for ape A-I and from 70% to 98% for apo B. The three SSRMsfor apo A-I and the three SSRMS for ape B selected for further evaluation had the lowest percentage of among-laboratory error, 68%, 56%, and 43%, respectively, for A5, All, and Al2, and 79%, 72%, and 70%, respectively, for B2, B7, and B8.
DIscussion
Clinical studies suggest that concentrations of apo A-I and B can be used in addition to those of total cholesterol, high-density lipoprotein cholesterol, and LDL cholesterol to classify correctly and reliably subjects in the general population at risk for coronary artery disease. To do so, the laboratory measurements of apo tion was observed (CV = 5%), whereas a CVof 6% was observed among those systems calibrated against purified ape A-I. This finding is easily explainable by differences in ape A-I purification, assignment of protein mass, and different immunochemical behavior of purified ape A-I relative to ape A-I in plasma in some systems. Interestingly, the absolute difference in K factor among the systems calibrated against CDC 1883 and those calibrated against purified ape A-I would no longer be significant if, instead of using for CDC 1883 the value of 1.12 g/L that was originally assigned by consensus (8), the new value of 1.24 g/L recently determined by CDC against purified ape A-I were used.
Unlike Ape A-I, wide differences were observed (CV = 19%) among calibrations of the different systems for ape B. The mean K factor for the systems calibrated against CDC 1883 was much greater than that of the systems calibrated against purified LDL (1.52 vs 1.14). This finding can be explained by the fact that the ape B value for CDC 1883, assigned by consensus, was about 0.25 g/L less than the value obtained by a candidate reference method (5). However, regardless of how the systems were calibrated, with either common lyephilized secondary reference material or LDL, calibration differences among systems were high (CV = 12% and 15%, respectively). This finding clearly illustrates that numerous factors play an important role in the calibration of the immunosystems for ape B. These factors include ape B method-specific sensitivity to lyophilized material (3), variability in LDL preparations, possibility of modification of LDL upon storage (e.g., aggregation, denaturation, chemical modification), and differential immunoreactivity of isolated LDL from plasma LDL in some systems. All of these emphasize the need for a suitable reference material to transfer the target value to the different calibrators.
The second aim of this study was to verify that comparable ape A-I and B results can be achieved by different methods if fresh-frozen serum pools are used to correct the values of the different calibrators. Indeed, by this approach, the mean CV of ape A-I values of 10 samples was reduced from 7% to 5% and, more dramatically, the mean CV of ape B values was reduced from 19% to 6%. These results clearly indicate that comparability of the data can be achieved by using suitable reference material, even for as difficult an analyte as ape B.
The third aim of this study was to evaluate the preparations proposed by several participants for their suitability as candidate reference materials.
Among the 15 preparations prepared as candidate reference material for ape A-I, 10 exhibited a high CV among the different methods, ranging from 8.8% to 80.6%, indicating a high degree of matrix effect. All six ape A-I preparations in liquid-stabilized form had high among-method CVs, suggesting that this form of preparation does not preserve the physicochemical properties of ape A-I. Among the five preparations with low CVs, two were subsequently excluded for having a lipid layer and high blank. The among-method CVs of the three selected preparations were <5%, similar to those observed with fresh-frozen serum samples. In addition, these three preparations appeared to have composition and electrophoretic mobility similar to that of a fresh serum pool when analyzed by electrophoresis. Of the 11 ape B preparations, only three (all in liquid-stabilized form) exhibited an among-method CV comparable with that of the fresh-frozen serum pools; these were selected as candidate reference materials for further evaluation.
Although the stability of the SSRMs was not quantified, the visual observations of clarity and homogeneity serve as an index of overall stability. Many of the candidate SSRMs failed to meet this criterion. Furthermore, qualitative analysis with agarose gels is important in that this accurately depicts the physical composition of each SSRM and helps to explain many of the discordant findings observed in the calibration experiment. Pools that presented atypical qualitative characteristics (e.g., turbidity, lipid layer, or abnormal electrophoretic patterns) also had greater within-and amonglaboratory CVs or yielded nonlinear results in the dilution studies. More importantly, the simple qualitative electrophoretic assessment in combination with the quantitative data helped to differentiate suitable from unsuitable reference materials and supported the selection of the final three preparations for ape A-I (A5, All, A12) and ape B (B2, B7, B8) SSRMs.
The second phase of this international study will consist of a careful evaluation of the selected preparations to indicate whether an international reference material for ape A-I and B can be chosen from them.
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